Drug Clinical Trials Research
Clinical trial data for 100 drugs under active research. See drug-by-drug comparison pages →
Azirkitug
Azirkitug clinical trials: 1 studies for Gastric/Esophageal Cancer and Head and Neck Squamous Cell Carcinoma, 1 recruiting. Side effects, dosing, and results...
Tuspetinib
Tuspetinib clinical trials: 1 studies for Chronic Myelomonocytic Leukemia and Leukemia, Myeloid, Acute, 1 recruiting. Side effects, dosing, and results from ...
MRTX1719
MRTX1719 clinical trials: 2 studies for Solid Tumor and Advanced Solid Tumor, 2 recruiting. Side effects, dosing, and results from completed trials.
Surabgene Lomparvovec
Surabgene Lomparvovec clinical trials: 2 studies for Diabetic Retinopathy and Neovascular Age-related Macular Degeneration, 2 recruiting. Side effects, dosin...
Gocatamig
Gocatamig clinical trials: 3 studies for Neuroendocrine Carcinoma and Small-Cell Lung Cancer, 2 recruiting. Side effects, dosing, and results from completed ...
IMNN-001
IMNN-001 clinical trials: 4 studies for Fallopian Tube Cancer and Epithelial Ovarian Cancer, 2 recruiting. Side effects, dosing, and results from completed t...
Enobosarm
Enobosarm clinical trials: 6 studies for Metastatic Breast Cancer and Estrogen Receptor Negative, 1 recruiting. Side effects, dosing, and results from comple...
Iadademstat
Iadademstat clinical trials: 8 studies for Acute Myeloid Leukemia and Acute Myeloid Leukemia Refractory, 5 recruiting. Side effects, dosing, and results from...
daraxonrasib
daraxonrasib clinical trials: 8 studies for PDAC and Pancreatic Cancer, 6 recruiting. Side effects, dosing, and results from completed trials.
Emavusertib
Emavusertib clinical trials: 9 studies for Myelodysplastic Syndrome and Acute Myeloid Leukemia, 6 recruiting. Side effects, dosing, and results from complete...
Bimagrumab
Bimagrumab clinical trials: 11 studies for Obesity and Sarcopenia, 1 recruiting. Side effects, dosing, and results from completed trials.
Etentamig
Etentamig clinical trials: 11 studies for Multiple Myeloma and Relapsed/Refractory Multiple Myeloma, 6 recruiting. Side effects, dosing, and results from com...
Golcadomide
Golcadomide clinical trials: 15 studies for Refractory Primary Mediastinal Large B-Cell Lymphoma and Large B-cell Lymphoma, 7 recruiting. Side effects, dosin...
Pumitamig
Pumitamig clinical trials: 17 studies for Advanced Solid Tumor and Non-small Cell Lung Cancer, 15 recruiting. Side effects, dosing, and results from complete...
Retifanlimab
Retifanlimab clinical trials: 56 studies for Breast Cancer and Merkel Cell Carcinoma, 16 recruiting. Side effects, dosing, and results from completed trials.
Fostamatinib
Fostamatinib clinical trials: 62 studies for Rheumatoid Arthritis and Pharmacokinetics, 5 recruiting. Side effects, dosing, and results from completed trials.
Polatuzumab Vedotin
Polatuzumab Vedotin clinical trials: 80 studies for Diffuse Large B-Cell Lymphoma and Diffuse Large B Cell Lymphoma, 30 recruiting. Side effects, dosing, and...
Dostarlimab
Dostarlimab clinical trials: 87 studies for Neoplasms and Endometrial Cancer, 29 recruiting. Side effects, dosing, and results from completed trials.
Tremelimumab
Tremelimumab clinical trials: 234 studies for Hepatocellular Carcinoma and Colorectal Cancer, 40 recruiting. Side effects, dosing, and results from completed...
Daratumumab
Daratumumab clinical trials: 347 studies for Multiple Myeloma and Plasma Cell Myeloma, 85 recruiting. Side effects, dosing, and results from completed trials.
Ibrutinib
Ibrutinib clinical trials: 352 studies for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma, 39 recruiting. Side effects, dosing, and results from compl...
Olaparib
Olaparib clinical trials: 409 studies for Ovarian Cancer and Breast Cancer, 83 recruiting. Side effects, dosing, and results from completed trials.
Ranibizumab
Ranibizumab clinical trials: 480 studies for Diabetic Macular Edema and Macular Edema, 11 recruiting. Side effects, dosing, and results from completed trials.
Venetoclax
Venetoclax clinical trials: 686 studies for Acute Myeloid Leukemia and Chronic Lymphocytic Leukemia, 259 recruiting. Side effects, dosing, and results from c...
Durvalumab
Durvalumab clinical trials: 732 studies for Hepatocellular Carcinoma and Non-small Cell Lung Cancer, 162 recruiting. Side effects, dosing, and results from c...
Rituximab
Rituximab clinical trials: 2053 studies for Lymphoma and Chronic Lymphocytic Leukemia, 264 recruiting. Side effects, dosing, and results from completed trials.
APL-3007, pegcetacoplan (APL-2)
APL-3007, pegcetacoplan (APL-2) clinical trials: 1 studies for Geographic Atrophy Secondary to Age-related Macular Degeneration, 1 recruiting. Side effects, ...
Givastomig
Givastomig clinical trials: 2 studies for Solid Tumor and Metastatic Cancer, 2 recruiting. Side effects, dosing, and results from completed trials.
Pelabresib
Pelabresib clinical trials: 8 studies for Advanced Malignancies and Solid Tumor, 4 recruiting. Side effects, dosing, and results from completed trials.
Linvoseltamab
Linvoseltamab clinical trials: 20 studies for Multiple Myeloma and Smoldering Multiple Myeloma (SMM), 14 recruiting. Side effects, dosing, and results from c...
Monalizumab
Monalizumab clinical trials: 21 studies for Non-small Cell Lung Cancer and Adenocarcinoma of the Esophagus, 5 recruiting. Side effects, dosing, and results f...
Tafasitamab
Tafasitamab clinical trials: 50 studies for Diffuse Large B-cell Lymphoma and Chronic Lymphocytic Leukemia, 18 recruiting. Side effects, dosing, and results ...
Furmonertinib
Furmonertinib clinical trials: 56 studies for Non-small Cell Lung Cancer and NSCLC, 22 recruiting. Side effects, dosing, and results from completed trials.
Niraparib
Niraparib clinical trials: 199 studies for Ovarian Cancer and Ovarian Neoplasms, 34 recruiting. Side effects, dosing, and results from completed trials.
Trametinib
Trametinib clinical trials: 243 studies for Melanoma and Cancer, 39 recruiting. Side effects, dosing, and results from completed trials.
lazertinib(YH25448)
lazertinib(YH25448) clinical trials: 3 studies for EGFR Gene Mutation and Lung Neoplasms. Side effects, dosing, and results from completed trials.
ABBV-8736
ABBV-8736 clinical trials: 3 studies for Healthy Volunteer and Crohn's Disease, 1 recruiting. Side effects, dosing, and results from completed trials.
Finerenone (Kerendia, BAY948862)
Finerenone (Kerendia, BAY948862) clinical trials: 4 studies for Chronic Kidney Disease and Type 2 Diabetes Mellitus. Side effects, dosing, and results from c...
Efinopegdutide
Efinopegdutide clinical trials: 7 studies for Non-alcoholic Fatty Liver Disease and Nonalcoholic Fatty Liver Disease. Side effects, dosing, and results from ...
Avutometinib
Avutometinib clinical trials: 21 studies for KRAS Activating Mutation and Non Small Cell Lung Cancer, 12 recruiting. Side effects, dosing, and results from c...
Mosunetuzumab
Mosunetuzumab clinical trials: 54 studies for Follicular Lymphoma and Non-Hodgkin Lymphoma, 31 recruiting. Side effects, dosing, and results from completed t...
Dabrafenib
Dabrafenib clinical trials: 147 studies for Melanoma and Metastatic Melanoma, 27 recruiting. Side effects, dosing, and results from completed trials.
Navlimetostat
Navlimetostat clinical trials: 2 studies for Healthy Participants and Non-Small Cell Lung Cancer, 1 recruiting. Side effects, dosing, and results from comple...
Nadofaragene Firadenovec
Nadofaragene Firadenovec clinical trials: 6 studies for Bladder Cancer and CIS, 4 recruiting. Side effects, dosing, and results from completed trials.
Avacopan
Avacopan clinical trials: 15 studies for Acne Inversa and ANCA-Associated Vasculitis, 6 recruiting. Side effects, dosing, and results from completed trials.
Zibotentan
Zibotentan clinical trials: 18 studies for Liver Cirrhosis and Chronic Kidney Disease, 1 recruiting. Side effects, dosing, and results from completed trials.
Nemtabrutinib
Nemtabrutinib clinical trials: 21 studies for Chronic Lymphocytic Leukemia and Healthy, 7 recruiting. Side effects, dosing, and results from completed trials.
Sonrotoclax
Sonrotoclax clinical trials: 24 studies for Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma, 12 recruiting. Side effects, dosing, and results from comp...
Relatlimab
Relatlimab clinical trials: 90 studies for Melanoma and Metastatic Melanoma, 30 recruiting. Side effects, dosing, and results from completed trials.
Vorinostat
Vorinostat clinical trials: 272 studies for Lymphoma and Multiple Myeloma, 10 recruiting. Side effects, dosing, and results from completed trials.
Remibrutinib
Remibrutinib clinical trials: 18 studies for Relapsing Multiple Sclerosis and Chronic Spontaneous Urticaria, 8 recruiting. Side effects, dosing, and results ...
Pacritinib
Pacritinib clinical trials: 49 studies for Primary Myelofibrosis and Myelofibrosis, 17 recruiting. Side effects, dosing, and results from completed trials.
Savolitinib
Savolitinib clinical trials: 36 studies for Non-small Cell Lung Cancer and Carcinoma, 5 recruiting. Side effects, dosing, and results from completed trials.
Ipilimumab
Ipilimumab clinical trials: 791 studies for Melanoma and Metastatic Melanoma, 109 recruiting. Side effects, dosing, and results from completed trials.
ZL-1310
ZL-1310 clinical trials: 4 studies for SCLC and Small-cell Lung Cancer, 4 recruiting. Side effects, dosing, and results from completed trials.
GDC-4198
GDC-4198 clinical trials: 1 studies for Breast Cancer, 1 recruiting. Side effects, dosing, and results from completed trials.
Efineptakin alfa
Efineptakin alfa clinical trials: 5 studies for AIDS-Related Kaposi Sarcoma and Carcinoma, Non-Small-Cell Lung, 1 recruiting. Side effects, dosing, and resul...
ABBV-RGX-314 Dose 1
ABBV-RGX-314 Dose 1 clinical trials: 9 studies for Neovascular Age-related Macular Degeneration and Wet Age-related Macular Degeneration, 4 recruiting. Side ...
Cemdisiran
Cemdisiran clinical trials: 15 studies for Paroxysmal Nocturnal Hemoglobinuria and Healthy, 4 recruiting. Side effects, dosing, and results from completed tr...
Pozelimab
Pozelimab clinical trials: 18 studies for Paroxysmal Nocturnal Hemoglobinuria and CD55-deficient Protein-losing Enteropathy, 6 recruiting. Side effects, dosi...
Ropeginterferon alfa-2b
Ropeginterferon alfa-2b clinical trials: 27 studies for Polycythemia Vera and Myelofibrosis, 5 recruiting. Side effects, dosing, and results from completed t...
Defactinib
Defactinib clinical trials: 33 studies for Ovarian Cancer and Low Grade Serous Ovarian Cancer, 12 recruiting. Side effects, dosing, and results from complete...
Verteporfin
Verteporfin clinical trials: 46 studies for Macular Degeneration and Choroidal Neovascularization, 6 recruiting. Side effects, dosing, and results from compl...
Telitacicept
Telitacicept clinical trials: 46 studies for Systemic Lupus Erythematosus and Telitacicept, 17 recruiting. Side effects, dosing, and results from completed t...
Itacitinib
Itacitinib clinical trials: 50 studies for Hematologic and Lymphocytic Disorder and Solid Tumors, 3 recruiting. Side effects, dosing, and results from comple...
Cabozantinib
Cabozantinib clinical trials: 251 studies for Renal Cell Carcinoma and Metastatic Renal Cell Carcinoma, 60 recruiting. Side effects, dosing, and results from...
Relugolix
Relugolix clinical trials: 53 studies for Prostate Cancer and Prostate Adenocarcinoma, 21 recruiting. Side effects, dosing, and results from completed trials.
Tofacitinib
Tofacitinib clinical trials: 189 studies for Rheumatoid Arthritis and Ulcerative Colitis, 33 recruiting. Side effects, dosing, and results from completed tri...
Upadacitinib
Upadacitinib clinical trials: 103 studies for Atopic Dermatitis and Rheumatoid Arthritis, 33 recruiting. Side effects, dosing, and results from completed tri...
Atezolizumab
Atezolizumab clinical trials: 746 studies for Hepatocellular Carcinoma and Non-Small Cell Lung Cancer, 164 recruiting. Side effects, dosing, and results from...
Nivolumab
Nivolumab clinical trials: 1624 studies for Melanoma and Metastatic Melanoma, 273 recruiting. Side effects, dosing, and results from completed trials.
Lazertinib
Lazertinib clinical trials: 40 studies for Carcinoma, Non-Small-Cell Lung and Healthy, 8 recruiting. Side effects, dosing, and results from completed trials.
sigvotatug vedotin
sigvotatug vedotin clinical trials: 5 studies for Carcinoma, Non-Small Cell Lung and Non-Small Cell Lung Cancer, 3 recruiting. Side effects, dosing, and resu...
Telisotuzumab Vedotin
Telisotuzumab Vedotin clinical trials: 8 studies for Non-Small Cell Lung Cancer and Non Small Cell Lung Cancer, 3 recruiting. Side effects, dosing, and resul...
Odronextamab
Odronextamab clinical trials: 16 studies for Follicular Lymphoma (FL) and Refractory Diffuse Large B-Cell Lymphoma, 10 recruiting. Side effects, dosing, and ...
Saruparib
Saruparib clinical trials: 12 studies for Ovarian Cancer and Prostate Cancer, 10 recruiting. Side effects, dosing, and results from completed trials.
Calderasib
Calderasib clinical trials: 15 studies for Healthy and Non-small Cell Lung Cancer, 7 recruiting. Side effects, dosing, and results from completed trials.
Fianlimab
Fianlimab clinical trials: 37 studies for Melanoma and Non-small Cell Lung Cancer, 18 recruiting. Side effects, dosing, and results from completed trials.
zolbetuximab
zolbetuximab clinical trials: 16 studies for Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma and Gastric Cancer, 6 recruiting. Side effects, dosing...
Iberdomide
Iberdomide clinical trials: 35 studies for Multiple Myeloma and Refractory Multiple Myeloma, 19 recruiting. Side effects, dosing, and results from completed ...
Revumenib
Revumenib clinical trials: 19 studies for Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia, 11 recruiting. Side effects, dosing, and results from comp...
Adagrasib
Adagrasib clinical trials: 26 studies for Metastatic Cancer and Advanced Cancer, 7 recruiting. Side effects, dosing, and results from completed trials.
Epcoritamab
Epcoritamab clinical trials: 52 studies for Follicular Lymphoma and Diffuse Large B-Cell Lymphoma, 28 recruiting. Side effects, dosing, and results from comp...
Glofitamab
Glofitamab clinical trials: 74 studies for Mantle Cell Lymphoma and Lymphoma, 39 recruiting. Side effects, dosing, and results from completed trials.
Elranatamab
Elranatamab clinical trials: 46 studies for Multiple Myeloma and Refractory Multiple Myeloma, 28 recruiting. Side effects, dosing, and results from completed...
Teclistamab
Teclistamab clinical trials: 50 studies for Multiple Myeloma and Refractory Multiple Myeloma, 26 recruiting. Side effects, dosing, and results from completed...
Talquetamab
Talquetamab clinical trials: 36 studies for Multiple Myeloma and Relapsed or Refractory Multiple Myeloma, 18 recruiting. Side effects, dosing, and results fr...
Tarlatamab
Tarlatamab clinical trials: 32 studies for Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer, 17 recruiting. Side effects, dosing, and result...
RBS2418
RBS2418 clinical trials: 4 studies for Advanced Cancer and Advanced Colorectal Cancer, 3 recruiting. Side effects, dosing, and results from completed trials.
EYP-1901
EYP-1901 clinical trials: 8 studies for Diabetic Macular Edema and Wet Age Related Macular Degeneration, 2 recruiting. Side effects, dosing, and results from...
Lurbinectedin
Lurbinectedin clinical trials: 54 studies for Small Cell Lung Cancer and Advanced Solid Tumor, 15 recruiting. Side effects, dosing, and results from complete...
Rilvegostomig
Rilvegostomig clinical trials: 30 studies for Biliary Tract Cancer and Gastric Cancer, 26 recruiting. Side effects, dosing, and results from completed trials.
Leriglitazone
Leriglitazone clinical trials: 1 studies for Cerebral Adrenoleukodystrophy (cALD), 1 recruiting. Side effects, dosing, and results from completed trials.
ALZ-101
ALZ-101 clinical trials: 1 studies for Alzheimer Disease and Dementia Alzheimers. Side effects, dosing, and results from completed trials.
Sonesitatug vedotin
Sonesitatug vedotin clinical trials: 1 studies for Esophageal Cancer and Gastric Cancer, 1 recruiting. Side effects, dosing, and results from completed trials.
AVA6000
AVA6000 clinical trials: 1 studies for Breast Cancer and Ovarian Carcinoma, 1 recruiting. Side effects, dosing, and results from completed trials.
RGT-490
RGT-490 clinical trials: 1 studies for Advanced Breast Cancer and Breast Cancer, 1 recruiting. Side effects, dosing, and results from completed trials.
Opemalirsen (AZD2373)
Opemalirsen (AZD2373) clinical trials: 1 studies for Renal Impairment. Side effects, dosing, and results from completed trials.
JANX007
JANX007 clinical trials: 1 studies for Castration Resistant Prostatic Cancer and Metastatic Castration-resistant Prostate Cancer, 1 recruiting. Side effects,...
MZE829
MZE829 clinical trials: 1 studies for Proteinuric Kidney Disease, 1 recruiting. Side effects, dosing, and results from completed trials.